Association of CXCR3+ T-cell and NK-cell populations with plasma CXCL10 and CXCL9 in a subpopulation
Chemokine . | Controls (n = 67/65)* . | cGVHD cases (n = 52/44)* . | P . | ROC AUC . | ||
---|---|---|---|---|---|---|
Mean . | SD . | Mean . | SD . | |||
Replication set 1 | ||||||
CXCL10, pg/mL | 129 | 105 | 607 | 2194 | .04 | 0.61 |
CXCL9, pg/mL | 8969 | 9218 | 17715 | 18675 | .02 | 0.63 |
Subset (% of parent population)† | ||||||
CD3–CD56brightCXCR3+ | 12.6 | 10.8 | 10.3 | 11.5 | .03 | 0.62 |
CD8+CXCR3+ | 23.4 | 12.9 | 22.1 | 12.8 | .50 | 0.54 |
CD4+CXCR3+ | 13.2 | 8.5 | 11.0 | 8.2 | .10 | 0.59 |
Ratio CXCL10/% | ||||||
CD3–CD56brightCXCR3+ | 24.3 | 37.8 | 159 | 447 | .03 | 0.63 |
CD8+CXCR3+ | 7.9 | 9.2 | 35.2 | 103.2 | .13 | 0.58 |
CD4+CXCR3+ | 17.9 | 25.7 | 154 | 610 | .04 | 0.61 |
Ratio CXCL9/% | ||||||
CD3–CD56brightCXCR3+ | 1760 | 3090 | 7079 | 13023 | .008 | 0.65 |
CD8+CXCR3+ | 574 | 808 | 1256 | 1570 | .04 | 0.62 |
CD4+CXCR3+ | 1246 | 1883 | 3065 | 4870 | .01 | 0.64 |
Replication set 2 | (n = 25) | (n = 24) | ||||
CXCL10, pg/mL | 238.6 | 449.4 | 819.5 | 1370 | .005 | 0.73 |
CXCL9, pg/mL | 16036 | 25116 | 25805 | 31451 | .12 | 0.63 |
Subset (% of parent population)† | ||||||
CD3–CD56brightCXCR3+ | 16.0 | 10.62 | 9.37 | 5.73 | .01 | 0.70 |
CD8+CXCR3+ | 25.64 | 15.02 | 25.39 | 12.69 | .98 | 0.51 |
CD4+CXCR3+ | 2.38 ± 2.43 | 1.90 | 2.32 | .38 | 0.57 | |
Ratio CXCL10/% | ||||||
CD3–CD56brightCXCR3+ | 19.08 | 31.48 | 143.0 | 201.9 | .0009 | 0.78 |
CD8+CXCR3+ | 14.43 | 33.96 | 48.6 | 113.7 | .006 | 0.73 |
CD4+CXCR3+ | 223.3 | 336.1 | 1087 | 2371 | .008 | 0.72 |
Ratio CXCL9/% | ||||||
CD3–CD56brightCXCR3+ | 1155 | 1350 | 5887 | 11457 | .05 | 0.67 |
CD8+CXCR3+ | 848 | 1208 | 1105 | 1308 | .12 | 0.63 |
CD4+CXCR3+ | 22075 | 53070 | 29705 | 35102 | .08 | 0.65 |
Chemokine . | Controls (n = 67/65)* . | cGVHD cases (n = 52/44)* . | P . | ROC AUC . | ||
---|---|---|---|---|---|---|
Mean . | SD . | Mean . | SD . | |||
Replication set 1 | ||||||
CXCL10, pg/mL | 129 | 105 | 607 | 2194 | .04 | 0.61 |
CXCL9, pg/mL | 8969 | 9218 | 17715 | 18675 | .02 | 0.63 |
Subset (% of parent population)† | ||||||
CD3–CD56brightCXCR3+ | 12.6 | 10.8 | 10.3 | 11.5 | .03 | 0.62 |
CD8+CXCR3+ | 23.4 | 12.9 | 22.1 | 12.8 | .50 | 0.54 |
CD4+CXCR3+ | 13.2 | 8.5 | 11.0 | 8.2 | .10 | 0.59 |
Ratio CXCL10/% | ||||||
CD3–CD56brightCXCR3+ | 24.3 | 37.8 | 159 | 447 | .03 | 0.63 |
CD8+CXCR3+ | 7.9 | 9.2 | 35.2 | 103.2 | .13 | 0.58 |
CD4+CXCR3+ | 17.9 | 25.7 | 154 | 610 | .04 | 0.61 |
Ratio CXCL9/% | ||||||
CD3–CD56brightCXCR3+ | 1760 | 3090 | 7079 | 13023 | .008 | 0.65 |
CD8+CXCR3+ | 574 | 808 | 1256 | 1570 | .04 | 0.62 |
CD4+CXCR3+ | 1246 | 1883 | 3065 | 4870 | .01 | 0.64 |
Replication set 2 | (n = 25) | (n = 24) | ||||
CXCL10, pg/mL | 238.6 | 449.4 | 819.5 | 1370 | .005 | 0.73 |
CXCL9, pg/mL | 16036 | 25116 | 25805 | 31451 | .12 | 0.63 |
Subset (% of parent population)† | ||||||
CD3–CD56brightCXCR3+ | 16.0 | 10.62 | 9.37 | 5.73 | .01 | 0.70 |
CD8+CXCR3+ | 25.64 | 15.02 | 25.39 | 12.69 | .98 | 0.51 |
CD4+CXCR3+ | 2.38 ± 2.43 | 1.90 | 2.32 | .38 | 0.57 | |
Ratio CXCL10/% | ||||||
CD3–CD56brightCXCR3+ | 19.08 | 31.48 | 143.0 | 201.9 | .0009 | 0.78 |
CD8+CXCR3+ | 14.43 | 33.96 | 48.6 | 113.7 | .006 | 0.73 |
CD4+CXCR3+ | 223.3 | 336.1 | 1087 | 2371 | .008 | 0.72 |
Ratio CXCL9/% | ||||||
CD3–CD56brightCXCR3+ | 1155 | 1350 | 5887 | 11457 | .05 | 0.67 |
CD8+CXCR3+ | 848 | 1208 | 1105 | 1308 | .12 | 0.63 |
CD4+CXCR3+ | 22075 | 53070 | 29705 | 35102 | .08 | 0.65 |